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The pathogenesis of avian inﬂ  uenza A (H5N1) virus in 
humans has not been clearly elucidated. Apoptosis may also 
play an important role. We studied autopsy specimens from 
2 patients who died of infection with this virus. Apoptosis 
was observed in alveolar epithelial cells, which is the major 
target cell type for the viral replication. Numerous apoptotic 
leukocytes were observed in the lung of a patient who died 
on day 6 of illness. Our data suggest that apoptosis may 
play a major role in the pathogenesis of inﬂ  uenza (H5N1) 
virus in humans by destroying alveolar epithelial cells. This 
pathogenesis causes pneumonia and destroys leukocytes, 
leading to leukopenia, which is a prominent clinical feature 
of inﬂ   uenza (H5N1) virus in humans. Whether observed 
apoptotic cells were a direct result of the viral replication or 
a consequence of an overactivation of the immune system 
requires further studies.
T
he pathogenesis of avian inﬂ  uenza A (H5N1) virus in 
humans is not well understood. Although several stud-
ies have shown some aspects of this pathogenesis in animal 
models, direct evidence of pathogenic mechanisms in hu-
mans has been limited to only a few autopsy studies (1–3). 
We previously demonstrated in an autopsy case that alveo-
lar epithelial cells are the major target cell type of this virus 
(3). The case in that study, as well as other previous autopsy 
reports, died late in the disease. Some of the ﬁ  ndings may 
not reﬂ  ect the actual pathogenesis at the acute period but 
may be consequences of secondary events. We performed 
an autopsy of a patient who died on day 6 of onset of ill-
ness. The ﬁ  ndings in this case are more likely to reﬂ  ect vi-
ral pathogenesis in the acute phase of the disease.
Apoptosis has been implicated in the pathogenesis of 
inﬂ   uenza. Infection of epithelial cells and lymphocytes 
has been shown to induce apoptosis in vitro (4–8). Several 
modes of apoptosis induction and responsible viral genes 
have been proposed (8–13). Infection with virulent inﬂ  u-
enza (H5N1) virus was also shown to induce lymphopenia 
and lymphocyte apoptosis in vivo (14). However, whether 
and to what extent apoptosis contributes to the highly viru-
lence property of inﬂ  uenza (H5N1) viruses are not clear. In 
this report, we studied apoptotic activity in 2 patients who 
died of avian inﬂ  uenza.
Materials and Methods
Patients
The study was approved by the Siriraj Ethics Commit-
tee. The ﬁ  rst patient (patient A) was a 48-year-old man who 
had progressive viral pneumonia. He had fever, cough, run-
ning nose, myalgia, and chest pain at the onset of illness. 
Dyspnea developed on day 2 of illness, and a chest radio-
graph showed interstitial inﬁ  ltrations at right upper and left 
middle lung ﬁ  elds and a masslike inﬁ  ltration at the right 
middle lung ﬁ  eld. The diagnosis of avian inﬂ  uenza was 
suspected on day 4 of illness after a history of direct contact 
with dying chickens was revealed. Respiratory secretions 
were then sent to national laboratories and conﬁ  rmed posi-
tive for inﬂ  uenza (H5N1) virus. The patient died on day 6 
of illness.
An autopsy was conducted by using standard tech-
niques and precautions to minimize risk for transmission 
of infection. Tissues obtained were prepared for routine 
histologic analysis and samples were stored at −70°C for 
further study. 
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The other autopsy case (patient B) has been previously 
reported (3). This patient was a 6-year-old boy who had 
progressive viral pneumonia that led to acute respiratory 
distress syndrome and death 17 days after onset of illness.
RNA, Antigen, and Apoptosis Analyses
Lung, trachea, liver, spleen, colon, and bone marrow 
tissues were tested for viral RNA. For reverse transcrip-
tion–PCR (RT-PCR), fresh unﬁ  xed specimens were minced 
into small pieces in lysis buffer of an RNA extraction kit 
(RN easy; QIAGEN, Valencia, CA, USA). Total RNA was 
then extracted according to the manufacturer’s protocol. 
RT-PCR for hemagglutinin 5 (H5) was then performed 
on the extracted RNA by using the One-Step RT-PCR Kit 
(QIAGEN) with an H5-speciﬁ  c primer pair. Strand-speciﬁ  c 
RT-PCR was performed by using a method similar to the 
RT-PCR for viral RNA detection except that only 1 primer 
was added at the reverse transcription step. Tumor necrosis 
factor-α (TNF-α) mRNA was detected in RNA extracted 
from lung, trachea, liver, spleen, colon, and bone marrow 
tissues by an RT-PCR as previously described (3).
Tissue sections of lung, trachea, liver, spleen, and co-
lon were stained for inﬂ  uenza A virus antigen. The sec-
tions were deparafﬁ  nized and rehydrated. Antigenic sites 
were identiﬁ  ed by digestion with 0.5% trypsin for 15 min at 
37°C. Endogenous peroxidase activity was blocked by in-
cubating sections in 3% H2O2 for 15 min at 37°C. Sections 
were incubated with 2.5% bovine serum albumin (Dako, 
Roskilde, Denmark) for 15 min at room temperature and 
subsequently incubated with a monoclonal antibody to in-
ﬂ  uenza A virus nucleoprotein at a dilution of 1:40 (B.V. 
European Veterinary Laboratory, Woerden, the Nether-
lands) overnight at 4°C. Slides were rinsed 3 times in 1× 
phosphate-buffered saline (PBS) plus 0.05% Tween-20 and 
incubated with horseradish peroxidase–conjugated goat an-
timouse immunoglobulins at dilutions of 1:400 (Dako) for 
30 min at room temperature. The slides were washed as 
above and developed with diaminobenzidine (Dako).
Lung, liver, spleen, colon, and bone marrow sections 
were analyzed for apoptosis by using the terminal deoxy-
nucleotidyl transferase-mediated dUTP-biotin nick end-la-
beling (TUNEL) assay. After digestion with 0.5% trypsin 
as described above, sections were treated with TUNEL re-
action mixture by using the In Situ Cell Death Detection 
Kit (Boehringer, Mannheim, Germany) for 1 h at 37°C in 
the dark. Slides were then rinsed 3 times with 1× PBS and 
incubated with alkaline phosphatase–conjugated ﬂ  uores-
cein isothiocyanate–labeled antibody for 30 min at 37°C. 
Sections were then washed and developed with nitro-blue 




Pathologic ﬁ  ndings in patient A were not identical to 
the previously reported ﬁ  ndings in patient B (3). Common 
ﬁ  ndings in both patients were diffuse alveolar damage and 
positive staining for inﬂ  uenza A virus antigen in alveolar 
epithelial cells (Figure 1). In patient A, lungs showed an 
earlier stage of exudative phase of diffuse alveolar damage 
than the damage found in patient B. Patient A also showed 
some atypical pneumocytes with large bizarre and clump-
ing nuclei. Bronchiolitis and pleuritis were also observed. 
No superimposed bacterial or fungal infection was identi-
ﬁ  ed. Hemophagocytic activity was found in lungs, liver, 
and bone marrow. The liver showed some cholestasis but 
was otherwise unremarkable.
Sites of Viral Replication
Viral RNA was detectable in the lung, trachea, and liv-
er of patient A (Figure 2A). To test whether virus replicated 
outside the lung, we tested the trachea and liver by using a 
strand-speciﬁ  c RT-PCR and found that both tissues con-
tained positive-stranded viral RNA, which suggested active 
viral replication in these organs. This was in contrast to our 
previous report (patient B), in which positive-stranded viral 
RNA was detectable in lung and intestine (3). Whether this 
was a result of a difference in tissue tropism of the viruses 
is unclear. It is also possible that this reﬂ  ected different 
Figure 1. Immunohistochemical staining of viral antigen in alveolar 
epithelial cells of patient A infected with avian inﬂ  uenza A (H5N1) 
virus (magniﬁ  cation ×100). RESEARCH
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phases of the disease course between the 2 patients. The 
ﬁ  nding also indicated that viral replication was maintained 
in the lung throughout the course of the disease. This was in 
agreement with the ﬁ  nding in both patients that viral anti-
gen was detectable by immunohistochemical analysis only 
in alveolar epithelial cells of the lungs, which indicated that 
this cell type is the major target cell in humans.
Apoptosis
Apoptosis was frequently observed in hyperprolifer-
ating alveolar epithelial cells (Figure 3A) in lung tissues 
from patient B. In patient A, apoptosis was prominent in 
leukocytes that inﬁ  ltrated the lung, but apoptotic alveolar 
epithelial cells were less frequent partly because epithelial 
cells were mostly absent, which left alveolar surface de-
nuded (Figure 3B). We have previously shown that TNF-α 
mRNA was upregulated in the lung of patient B (3), which 
may be 1 of the mechanisms leading to apoptosis. Similar-
ly, we tested the lung of patient A and found upregulation 
of TNF-α mRNA. We also tested trachea, liver, spleen, co-
lon, and bone marrow tissues of this patient; TNF-α mRNA 
was detectable only in the liver (Figure 2B).
To compare these ﬁ  ndings with those of viral pneumo-
nia caused by human inﬂ  uenza virus, we searched archival 
pathologic specimens for lung tissues with histopathologic 
ﬁ  ndings compatible with viral pneumonia. The specimens 
were then tested for inﬂ  uenza A virus by RT-PCR. A vi-
rus-positive specimen was stained for apoptosis. This lung 
specimen was from a 47-year-old man who sought medi-
cal attention because of fever and hemoptysis. A lung 
biopsy was performed to investigate the cause of hemop-
tysis. Pathologic examination showed bronchiectasis and 
interstitial pneumonia. The patient responded to supportive 
care and recovered. In comparison with lungs infected with 
inﬂ  uenza (H5N1) virus, no apoptotic alveolar epithelial 
cells were detected in this lung tissue that contained human 
inﬂ  uenza virus. However, apoptotic leukocytes inﬁ  ltrating 
the lung were as prominent as in patient A (Figure 3C).
Apoptotic lymphocytes were abundant in the red pulp 
and occasionally observed in the white pulp (Figure 3D) 
of the spleens of both patients. In contrast, a normal spleen 
specimen showed only a minimal number of apoptotic cells 
(Figure 3E). We also observed apoptotic cells in intesti-
nal epithelial cells of patients A and B. Liver samples from 
patient A did not show large numbers of apoptotic cells 
despite the presence of replicating viral RNA and TNF-α 
mRNA. The lack of apoptosis in the liver and other organs 
and cell types indicated that the observed apoptotic cells 
in lungs, spleens, and intestines were speciﬁ  c to the patho-
logic process and not due to postmortem changes.
Because leukopenia and thrombocytopenia are promi-
nent clinical features of infection with inﬂ  uenza (H5N1) 
virus (15), we investigated whether bone marrow failure 
plays a role in addition to increased destruction by apop-
tosis of leukocytes in the lung. We stained bone marrow 
samples from both patients for a proliferation marker, Ki-
67, and an apoptotic marker. These samples showed nor-
mal levels of Ki-67+–proliferating cells when compared 
with normal bone marrow samples. The number of apop-
totic cells in bone marrow did not increase. This ﬁ  nding 
suggested that bone marrow may maintain normal function 
during infection with inﬂ  uenza (H5N1) virus and is likely 
not responsible for the leukopenia and thrombocytopenia.
Discussion
Loss of alveolar epithelial is probably 1 of the patho-
genic mechanisms of pneumonia caused by inﬂ  uenza 
(H5N1) virus, and apoptosis is at least partly responsible. 
The hyperproliferation of pneumocytes observed in patient 
B was likely the regenerative process in the late phase of the 
disease. Whether the apoptosis of alveolar epithelial cells 
was a direct result of infection in those cells or an indirect 
consequence caused by cytokine dysregulation is not yet 
clear. Expression of inﬂ  uenza viral genes has been shown 
to induce apoptosis in infected cells (8–13). These viral 
genes likely play a role in induction of apoptosis. However, 
the role of cytokines in apoptosis in pneumocytes cannot 
be excluded.
Lymphopenia has been shown to be a predictive mark-
er for acute respiratory distress syndrome and death (15). 
Figure 2. A) Detection of viral RNA in lung, trachea, and liver by 
reverse transcription–PCR (RT-PCR) (upper panel) and detection 
of positive- and negative-stranded viral RNA in trachea and liver by 
strand-speciﬁ  c RT-PCR (lower panel). Lane 1, 100-bp ladder; Neg, 
negative. B) RT-PCR showing overexpression of tumor necrosis 
factor-α in lung and liver tissues of patient in A compared with 
normal tissues.Apoptosis and Avian Inﬂ  uenza A (H5N1) Virus
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Infection of primary human lymphocytes in vitro has been 
shown to induce apoptosis (7). Increased  apoptosis leading 
to severe lymphopenia was likely evidence of more active 
viral replication and higher viral load. Because we did not 
ﬁ  nd evidence of viral replication in the spleen of patient A, 
which contained many apoptotic cells, lymphocyte apop-
tosis may not be a direct consequence of infection in these 
cells. Apoptosis of lymphocytes may have been caused 
indirectly by cytokine dysregulation and overactivation of 
the immune response. 
Because we also found numerous apoptotic leukocytes 
in lungs of a person infected with inﬂ  uenza virus and leu-
kopenia is not a prominent clinical feature of human inﬂ  u-
enza, apoptosis of inﬁ  ltrating leukocytes in inﬂ  amed tissue 
alone may not be sufﬁ   cient to cause leukopenia. Con-
versely, systemic cytokine dysregulation during infection 
with inﬂ  uenza (H5N1) virus may cause massive apoptosis 
in lymphoid organs, which leads to lymphopenia. Another 
possible explanation is that apoptosis was induced locally 
while lymphocytes were circulating through the infected 
lung, Determining if apoptotic lymphocytes can be directly 
detected in patients’ blood and can be a predictive marker 
for disease outcome requires further studies. 
Apoptosis could not be detected in the liver despite 
the presence of viral RNA and TNF-α mRNA. The liver 
did not show severe inﬂ  ammation as observed in the lung, 
which suggests that without apoptosis viral infection would 
not cause severe tissue damage. This ﬁ  nding underscores 
the role of apoptosis in viral pathogenesis. Conversely, 
absence of apoptotic cells in the liver may indicate that 
viral replication in this organ was not sufﬁ  cient to induce 
apoptosis and pathologic changes. The absence of apop-
tosis in the liver, despite the presence of TNF-α mRNA, 
suggests that expression of TNF-α alone may not be the 
major mechanism responsible for induction of apoptosis in 
pathogenesis of inﬂ  uenza virus.
We did not detect viral antigen in other organs, despite 
the presence of viral RNA. This ﬁ  nding suggested that al-
though other cell types were permissive for replication of 
viral RNA, this replication in these cells was inefﬁ  cient. 
This is in contrast to the widespread presence of viral anti-
gen in animal tissues and probably reﬂ  ects the interspecies 
barrier and incomplete adaptation of inﬂ  uenza (H5N1) virus 
to the human host. Although a recent reported showed that 
upper airway epithelium of humans lacks the α-2,3–linked 
sialic acid receptor for avian inﬂ  uenza virus (16), other in 
vitro data suggest that α-2,3–linked sialic acid is expressed 
in ciliated columnar epithelial cells of the airway (17,18). 
Recent in vitro experiments showed that the α-2,3–linked 
sialic acid receptor speciﬁ  c for avian inﬂ  uenza virus repli-
cates and spreads poorly in cultured differentiated human 
tracheobronchial epithelial cells (19,20). This ﬁ  nding is 
Figure 3. Terminal deoxynucleotidyl transferase–mediated dUTP-biotin nick end-labeling staining showing numerous apoptotic alveolar 
epithelial cells in lung of patient B (A) and leukocytes in lung of patient A (B). C) Lung tissue from a patient with pneumonia caused by 
human inﬂ  uenza A (H5N1) virus showing apoptosis only in leukocytes. D) Spleen of patient B showing numerous apoptotic cells. E) 
Normal spleen tissue showing only a minimal level of apoptosis. Apoptotic cells are stained dark blue, and an apoptotic cell in each panel 
is indicated by an arrow. Magniﬁ  cation ×400 in A, B, and C; ×100 in D and E.RESEARCH
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consistent with our data, which showed no detectable viral 
antigen in the trachea and probably reﬂ  ects inefﬁ  cient in-
fection of inﬂ  uenza (H5N1) virus in this tissue.
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